KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Assets Average (2016 - 2025)

Emergent BioSolutions (EBS) has 15 years of Assets Average data on record, last reported at $1.4 billion in Q4 2025.

  • For Q4 2025, Assets Average fell 3.07% year-over-year to $1.4 billion; the TTM value through Dec 2025 reached $1.4 billion, down 3.07%, while the annual FY2025 figure was $1.4 billion, 15.71% down from the prior year.
  • Assets Average reached $1.4 billion in Q4 2025 per EBS's latest filing, down from $1.4 billion in the prior quarter.
  • Across five years, Assets Average topped out at $3.1 billion in Q1 2023 and bottomed at $1.4 billion in Q4 2025.
  • Average Assets Average over 5 years is $2.5 billion, with a median of $2.9 billion recorded in 2022.
  • Peak YoY movement for Assets Average: increased 25.56% in 2021, then fell 7.02% in 2023.
  • A 5-year view of Assets Average shows it stood at $2.9 billion in 2021, then rose by 4.07% to $3.0 billion in 2022, then dropped by 15.4% to $2.6 billion in 2023, then crashed by 44.09% to $1.4 billion in 2024, then decreased by 3.07% to $1.4 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Assets Average were $1.4 billion in Q4 2025, $1.4 billion in Q3 2025, and $1.4 billion in Q4 2024.